Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
China · Delayed Price · Currency is CNY 28.65
-0.09 (-0.31%)
At close: Apr 29, 2026
SHE:301263 Market Cap
SHE:301263 has a market cap or net worth of 12.13 billion as of April 29, 2026. Its market cap has increased by 41.90% in one year.
Market Cap
12.13B
Enterprise Value
11.99B
Revenue
674.49M
Ranking
n/a
PE Ratio
520.99
Stock Price
28.65
Market Cap Chart
Since March 29, 2022, SHE:301263's market cap has increased from 8.26B to 12.13B, an increase of 46.91%. That is a compound annual growth rate of 9.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 12.13B | -1.17% |
| Dec 31, 2025 | 12.28B | 93.40% |
| Dec 31, 2024 | 6.35B | -8.63% |
| Dec 29, 2023 | 6.95B | -9.56% |
| Dec 30, 2022 | 7.68B | -6.98% |
| Mar 29, 2022 | 8.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Hisun Pharmaceutical | 13.53B |
| Guobang Pharma | 13.39B |
| Shenzhen Chipscreen Biosciences | 13.08B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 12.91B |
| Shanghai Shyndec Pharmaceutical | 12.86B |
| Ningbo Menovo Pharmaceutical | 12.44B |
| Zhejiang Jiuzhou Pharmaceutical | 12.36B |
| Zhejiang Jingxin Pharmaceutical | 12.09B |